Walking limitation is significantly associated with five-year fracture risk, according to a study published online Jan. 23 in JAMA Network Open.
Jan 24, 2024
0
0
Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.
Jan 22, 2024
0
1
Individuals with inflammatory bowel disease (IBD) universally show increased prescription medication use years before diagnosis, according to a study published in the December issue of the American Journal of Gastroenterology.
Jan 19, 2024
0
0
Factors that affect medical decision-making among patients with hidradenitis suppurativa (HS) include suffering threshold, perceptions of treatment risk, treatment fatigue, understanding of the disease, and sources of information, ...
Jan 17, 2024
0
0
In the United States, breast cancer screening and treatment were associated with a 58% reduction in breast cancer mortality in 2019 compared with 1975, according to a study published in the Jan. 16 issue of the Journal of ...
Jan 17, 2024
0
10
The prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 in JAMA Oncology.
Jan 15, 2024
0
0
During the first year of the COVID-19 pandemic, the incidence of head and neck cancer (HNC) decreased, according to a study published online Jan. 11 in JAMA Otolaryngology-Head & Neck Surgery.
Jan 15, 2024
0
0
The rate of twin deliveries increased with increasing body mass index (BMI), and part of this association was explained by higher use of assisted reproductive technology (ART), according to a study published online Jan. 9 ...
Jan 12, 2024
0
0
US regulators on Friday approved Florida's plan to import prescription drugs from Canada, making it the first state to win such authorization, in a bid to lower costs for American consumers.
Jan 6, 2024
0
11
Lisocabtagene maraleucel (liso-cel), a chimeric antigen receptor (CAR) T-cell therapy, is cost-effective for second-line diffuse large B-cell lymphoma (DLBCL) therapy, according to a study published online Dec. 28 in Blood ...
Jan 4, 2024
0
0
